Halbert Hargrove Global Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $17.1K | Buy |
34
+2
| +6% | +$960 | ﹤0.01% | 275 |
|
|
2026
Q1 | $15.7K | Hold |
32
| – | – | ﹤0.01% | 263 |
|
|
2025
Q4 | $18.5K | Sell |
32
-18
| -36% | -$10.2K | ﹤0.01% | 255 |
|
|
2025
Q3 | $24.3K | Buy |
50
+1
| +2% | +$465 | ﹤0.01% | 237 |
|
|
2025
Q2 | $19.9K | Buy |
49
+4
| +9% | +$1.67K | ﹤0.01% | 190 |
|
|
2025
Q1 | $22.4K | Hold |
45
| – | – | ﹤0.01% | 191 |
|
|
2024
Q4 | $23.4K | Buy |
+45
| New | +$24.7K | ﹤0.01% | 186 |
|
|
2023
Q2 | – | Sell |
-1,258
| Closed | -$725K | – | 161 |
|
|
2023
Q1 | $725K | Buy |
1,258
+54
| +4% | +$30.4K | 0.05% | 61 |
|
|
2022
Q4 | $663K | Sell |
1,204
-85
| -7% | -$45K | 0.05% | 65 |
|
|
2022
Q3 | $654K | Buy |
1,289
+7
| +0.5% | +$3.92K | 0.05% | 66 |
|
|
2022
Q2 | $697K | Sell |
1,282
-16
| -1% | -$8.81K | 0.05% | 65 |
|
|
2022
Q1 | $766K | Buy |
1,298
+109
| +9% | +$62.6K | 0.05% | 65 |
|
|
2021
Q4 | $793K | Sell |
1,189
-114
| -9% | -$71.2K | 0.05% | 63 |
|
|
2021
Q3 | $745K | Sell |
1,303
-75
| -5% | -$41.2K | 0.05% | 52 |
|
|
2021
Q2 | $695K | Buy |
1,378
+79
| +6% | +$37.3K | 0.05% | 62 |
|
|
2021
Q1 | $593K | Sell |
1,299
-14
| -1% | -$6.68K | 0.04% | 61 |
|
|
2020
Q4 | $612K | Buy |
1,313
+150
| +13% | +$70.3K | 0.05% | 53 |
|
|
2020
Q3 | $514K | Buy |
1,163
+4
| +0.3% | +$1.65K | 0.05% | 48 |
|
|
2020
Q2 | $420K | Sell |
1,159
-85
| -7% | -$28.5K | 0.06% | 46 |
|
|
2020
Q1 | $353K | Sell |
1,244
-115
| -8% | -$36.3K | 0.06% | 45 |
|
|
2019
Q4 | $441K | Sell |
1,359
-52
| -4% | -$15.8K | 0.11% | 42 |
|
|
2019
Q3 | $411K | Sell |
1,411
-10
| -0.7% | -$2.86K | 0.11% | 46 |
|
|
2019
Q2 | $417K | Buy |
+1,421
| New | +$391K | 0.11% | 40 |
|
|
2019
Q1 | – | Sell |
-1,564
| Closed | -$350K | – | 77 |
|
|
2018
Q4 | $350K | Sell |
1,564
-104
| -6% | -$24.4K | 0.08% | 46 |
|
|
2018
Q3 | $407K | Sell |
1,668
-25
| -1% | -$5.75K | 0.11% | 35 |
|
|
2018
Q2 | $351K | Sell |
1,693
-3
| -0.2% | -$637 | 0.09% | 43 |
|
|
2018
Q1 | $350K | Buy |
1,696
+267
| +19% | +$56K | 0.09% | 39 |
|
|
2017
Q4 | $271K | Buy |
1,429
+5
| +0.4% | +$958 | 0.07% | 54 |
|
|
2017
Q3 | $269K | Sell |
1,424
-455
| -24% | -$82.4K | 0.07% | 51 |
|
|
2017
Q2 | $328K | Sell |
1,879
-269
| -13% | -$45.2K | 0.09% | 46 |
|
|
2017
Q1 | $330K | Sell |
2,148
-12
| -0.6% | -$1.83K | 0.08% | 50 |
|
|
2016
Q4 | $305K | Sell |
2,160
-13
| -0.6% | -$1.92K | 0.08% | 47 |
|
|
2016
Q3 | $346K | Sell |
2,173
-84
| -4% | -$12.9K | 0.1% | 41 |
|
|
2016
Q2 | $334K | Sell |
2,257
-152
| -6% | -$22.4K | 0.1% | 45 |
|
|
2016
Q1 | $341K | Sell |
2,409
-398
| -14% | -$53.3K | 0.12% | 43 |
|
|
2015
Q4 | $398K | Sell |
2,807
-12
| -0.4% | -$1.6K | 0.17% | 41 |
|
|
2015
Q3 | $345K | Sell |
2,819
-2,979
| -51% | -$388K | 0.17% | 48 |
|
|
2015
Q2 | $752K | Sell |
5,798
-204
| -3% | -$26.6K | 0.18% | 41 |
|
|
2015
Q1 | $806K | Buy |
6,002
+2,654
| +79% | +$342K | 0.26% | 40 |
|
|
2014
Q4 | $419K | Sell |
3,348
-80
| -2% | -$9.73K | 0.21% | 51 |
|
|
2014
Q3 | $417K | Sell |
3,428
-376
| -10% | -$45.7K | 0.12% | 68 |
|
|
2014
Q2 | $449K | Sell |
3,804
-189
| -5% | -$22.2K | 0.14% | 53 |
|
|
2014
Q1 | $480K | Sell |
3,993
-615
| -13% | -$73.1K | 0.15% | 44 |
|
|
2013
Q4 | $513K | Sell |
4,608
-649
| -12% | -$64.5K | 0.16% | 41 |
|
|
2013
Q3 | $484K | Sell |
5,257
-57
| -1% | -$5.16K | 0.16% | 43 |
|
|
2013
Q2 | $450K | Buy |
+5,314
| New | +$442K | 0.16% | 51 |
|
Other funds holding TMO
Halbert Hargrove Global Advisors's TMO Position: Q2 2026 in Review
Halbert Hargrove Global Advisors increased its Thermo Fisher Scientific (TMO) stake by 6.3% in Q2 2026, buying an estimated $960 and bringing the position to 34 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #275.
Halbert Hargrove Global Advisors first reported a position in TMO in Q2 2013 and has held it in 46 quarters since. The position peaked at $806K in Q1 2015. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Halbert Hargrove Global Advisors held 34 shares of Thermo Fisher Scientific worth $17.1K as of Q2 2026.
- Halbert Hargrove Global Advisors bought 2 Thermo Fisher Scientific shares in Q2 2026, an estimated $960.
- Thermo Fisher Scientific made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #275 holding.
- Halbert Hargrove Global Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 46 quarters since.
- Halbert Hargrove Global Advisors's Thermo Fisher Scientific position peaked at $806K in Q1 2015.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.